Medication Assisted Treatment (MAT) Commission Statute

Legal Authority : Chapter 208, Section 103 of the Acts of 2018

Purpose

Create aggregate demographic and geographic profiles of individuals who use medication-assisted treatment; examine the availability of and barriers to accessing medication-assisted treatment, including federal, state and local laws and regulations; determining the current utilization of, and projected need for, medication-assisted treatment in inpatient and outpatient settings, including, but not limited to, inpatient and residential substance use treatment facilities, inpatient psychiatric settings, pharmacy settings, mobile settings and primary care settings; identify ways to expand access to medication-assisted treatment in both inpatient and outpatient settings; identify ways to encourage practitioners to seek waivers to administer buprenorphine to treat patients with opioid use disorder; study the availability of and concurrent use of behavioral health therapy for individuals receiving medication-assisted treatment; and other related matters.

19 Members

  • the commissioner of public health or a designee, who shall serve as chair;
  • the executive director of the health policy commission or a designee;
  • the director of Medicaid or a designee;
  • the house and senate chairs of the joint committee on mental health, substance use, and recovery or their designees;
  • the ranking house and senate minority members of the joint committee on mental health, substance use and recovery or their designees;
  • representative of community health centers,
  • representative of a primary care provider with experience providing medication-assisted treatment,
  • representative who is an expert in substance use disorder treatment;
  • representative of the Massachusetts Medical Society;
  • representative of the Massachusetts Health and Hospital Association, Inc.;
  • representative of the Association for Behavioral Healthcare, Inc.;
  • representative of the Massachusetts Association of Behavioral Health Systems, Inc.;
  • representative of the Massachusetts Association of Health Plans, Inc.;
  • representative of Blue Cross Blue Shield of Massachusetts, Inc.;
  • representative of the Massachusetts Pharmacists Association;
  • representative of Advocates for Human Potential, Inc.; and
  • representative the Massachusetts Organization for Addiction Recovery, Inc.

Reporting

The commission shall file a report on its findings and recommendation, together with any recommendations for legislation, with the clerks of the house of representatives and the senate no later than August 2019

Help Us Improve Mass.gov with your feedback

Feedback